4//SEC Filing
Sermon Charles 4
Accession 0000950170-24-106426
CIK 0001719714other
Filed
Sep 12, 8:00 PM ET
Accepted
Sep 13, 4:57 PM ET
Size
7.5 KB
Accession
0000950170-24-106426
Insider Transaction Report
Form 4
Sermon Charles
General Counsel
Transactions
- Exercise/Conversion
Performance Based Restricted Stock Unit
2024-09-11−65,600→ 0 totalExercise: $0.00From: 2024-09-11Exp: 2025-01-25→ American Depository Shares (65,600 underlying) - Exercise/Conversion
American Depositary Shares representing Ordinary Shares
2024-09-11+65,600→ 249,987 total
Footnotes (3)
- [F1]Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.
- [F2]Represents performance-based restricted stock unit earned under the Issuer's 2019 Employee Incentive Plan (the "Plan"), that vested on September 11, 2024 based on satisfaction of ADS price threshold values over a two year performance period.
- [F3]Reporting Person also beneficially owns 4 ordinary shares, nominal value of GBP 0.003 per ordinary share, of the Issuer.
Documents
Issuer
Mereo BioPharma Group plc
CIK 0001719714
Entity typeother
Related Parties
1- filerCIK 0001687318
Filing Metadata
- Form type
- 4
- Filed
- Sep 12, 8:00 PM ET
- Accepted
- Sep 13, 4:57 PM ET
- Size
- 7.5 KB